Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Myxovirus Resistance Protein A in Antiviral Treatment Guidance of Respiratory Viral Infections

NCT06668025 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06668025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06668025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Myxovirus Resistance Protein A in Antiviral Treatment Guidance of Respiratory Viral Infections
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2024
Completion date
February 12, 2026
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, respiratory viral infections, sars cov-2